Imaging Study to Compare Effects of Darolutamide and Enzalutamide With Respect to Placebo on the Blood Flow in the Brain in Healthy Male Volunteers.

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 23, 2018

Primary Completion Date

October 1, 2019

Study Completion Date

November 5, 2019

Conditions

Cerebrovascular Circulation

Interventions

DRUG

Darolutamide (BAY1841788)

300 mg tablet darolutamide, once orally

DRUG

Enzalutamide

4 x 40 mg capsules, once orally

OTHER

Placebo

4 placebo tablets, once orally

Trial Locations (1)

Centre for Neuroimaging Sciences, King's College, London